vs
Fulgent Genetics, Inc.（FLGT）与READING INTERNATIONAL INC（RDI）财务数据对比。点击上方公司名可切换其他公司
Fulgent Genetics, Inc.的季度营收约是READING INTERNATIONAL INC的1.4倍（$71.1M vs $50.3M），Fulgent Genetics, Inc.同比增速更快（-3.2% vs -14.2%），过去两年READING INTERNATIONAL INC的营收复合增速更高（5.6% vs 0.1%）
Fulgent Genetics是一家分子诊断技术企业，开发并提供覆盖携带者筛查、肿瘤基因检测、传染病检测、遗传性疾病分析的多元基因检测服务，主要客户为北美地区的医疗机构、药企、科研院所及公共卫生组织。
雷丁公司是总部位于美国费城的铁路企业，1924年起在宾夕法尼亚州东部及周边各州提供客运与货运运输服务，直至1976年被联合铁路公司收购。
FLGT vs RDI — 直观对比
营收规模更大
FLGT
是对方的1.4倍
$50.3M
营收增速更快
FLGT
高出11.0%
-14.2%
两年增速更快
RDI
近两年复合增速
0.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $71.1M | $50.3M |
| 净利润 | — | $-2.6M |
| 毛利率 | 30.2% | — |
| 营业利润率 | 21.1% | -1.9% |
| 净利率 | — | -5.1% |
| 营收同比 | -3.2% | -14.2% |
| 净利润同比 | — | -14.5% |
| 每股收益（稀释后） | $0.04 | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLGTRDI
| Q1 26 | $71.1M | — | ||
| Q4 25 | $83.3M | $50.3M | ||
| Q3 25 | $84.1M | $52.2M | ||
| Q2 25 | $81.8M | $60.4M | ||
| Q1 25 | $73.5M | $40.2M | ||
| Q4 24 | $76.2M | $58.6M | ||
| Q3 24 | $71.7M | $60.1M | ||
| Q2 24 | $71.0M | $46.8M |
净利润FLGTRDI
| Q1 26 | — | — | ||
| Q4 25 | $-23.4M | $-2.6M | ||
| Q3 25 | $-6.6M | $-4.2M | ||
| Q2 25 | $-19.0M | $-2.7M | ||
| Q1 25 | $-11.5M | $-4.8M | ||
| Q4 24 | $-5.9M | $-2.2M | ||
| Q3 24 | $-14.6M | $-7.0M | ||
| Q2 24 | $-8.7M | $-12.8M |
毛利率FLGTRDI
| Q1 26 | 30.2% | — | ||
| Q4 25 | 39.1% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | 42.1% | — | ||
| Q1 25 | 38.6% | — | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 37.3% | — |
营业利润率FLGTRDI
| Q1 26 | 21.1% | — | ||
| Q4 25 | -43.5% | -1.9% | ||
| Q3 25 | -18.3% | -0.6% | ||
| Q2 25 | -24.1% | 4.8% | ||
| Q1 25 | -26.9% | -17.2% | ||
| Q4 24 | -21.2% | 2.6% | ||
| Q3 24 | -23.8% | -0.6% | ||
| Q2 24 | -26.6% | -16.4% |
净利率FLGTRDI
| Q1 26 | — | — | ||
| Q4 25 | -28.1% | -5.1% | ||
| Q3 25 | -7.9% | -8.0% | ||
| Q2 25 | -23.2% | -4.4% | ||
| Q1 25 | -15.7% | -11.8% | ||
| Q4 24 | -7.7% | -3.8% | ||
| Q3 24 | -20.4% | -11.7% | ||
| Q2 24 | -12.3% | -27.4% |
每股收益（稀释后）FLGTRDI
| Q1 26 | $0.04 | — | ||
| Q4 25 | — | $-0.11 | ||
| Q3 25 | — | $-0.18 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.21 | ||
| Q4 24 | — | $-0.11 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $23.4M | $10.5M |
| 总债务越低越好 | — | $185.1M |
| 股东权益账面价值 | — | $-18.2M |
| 总资产 | $1.2B | $434.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FLGTRDI
| Q1 26 | $23.4M | — | ||
| Q4 25 | $50.2M | $10.5M | ||
| Q3 25 | $117.6M | $8.1M | ||
| Q2 25 | $87.9M | $9.1M | ||
| Q1 25 | $67.3M | $5.9M | ||
| Q4 24 | $55.1M | $12.4M | ||
| Q3 24 | $58.0M | $10.1M | ||
| Q2 24 | $65.1M | $9.3M |
总债务FLGTRDI
| Q1 26 | — | — | ||
| Q4 25 | — | $185.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $202.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FLGTRDI
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $-18.2M | ||
| Q3 25 | $1.1B | $-12.1M | ||
| Q2 25 | $1.1B | $-7.7M | ||
| Q1 25 | $1.1B | $-8.1M | ||
| Q4 24 | $1.1B | $-4.4M | ||
| Q3 24 | $1.1B | $1.6M | ||
| Q2 24 | $1.1B | $6.5M |
总资产FLGTRDI
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $434.9M | ||
| Q3 25 | $1.2B | $435.2M | ||
| Q2 25 | $1.2B | $438.1M | ||
| Q1 25 | $1.2B | $441.0M | ||
| Q4 24 | $1.2B | $471.0M | ||
| Q3 24 | $1.2B | $495.7M | ||
| Q2 24 | $1.2B | $494.9M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $4.3M |
| 自由现金流经营现金流 - 资本支出 | — | $4.1M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | — | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-2.9M |
8季度趋势，按日历期对齐
经营现金流FLGTRDI
| Q1 26 | — | — | ||
| Q4 25 | $-78.1M | $4.3M | ||
| Q3 25 | $11.1M | $295.0K | ||
| Q2 25 | $-30.2M | $1.6M | ||
| Q1 25 | $-4.4M | $-7.7M | ||
| Q4 24 | $25.0M | $8.0M | ||
| Q3 24 | $-15.5M | $1.3M | ||
| Q2 24 | $4.3M | $-10.4M |
自由现金流FLGTRDI
| Q1 26 | — | — | ||
| Q4 25 | $-83.1M | $4.1M | ||
| Q3 25 | $5.1M | $-246.0K | ||
| Q2 25 | $-37.0M | $1.2M | ||
| Q1 25 | $-9.1M | $-8.0M | ||
| Q4 24 | $21.2M | $7.0M | ||
| Q3 24 | $-35.0M | $-1.1M | ||
| Q2 24 | $-8.7M | $-10.6M |
自由现金流率FLGTRDI
| Q1 26 | — | — | ||
| Q4 25 | -99.7% | 8.2% | ||
| Q3 25 | 6.0% | -0.5% | ||
| Q2 25 | -45.2% | 1.9% | ||
| Q1 25 | -12.5% | -19.8% | ||
| Q4 24 | 27.9% | 12.0% | ||
| Q3 24 | -48.8% | -1.8% | ||
| Q2 24 | -12.2% | -22.7% |
资本支出强度FLGTRDI
| Q1 26 | — | — | ||
| Q4 25 | 6.0% | 0.3% | ||
| Q3 25 | 7.2% | 1.0% | ||
| Q2 25 | 8.3% | 0.6% | ||
| Q1 25 | 6.4% | 0.6% | ||
| Q4 24 | 5.0% | 1.7% | ||
| Q3 24 | 27.2% | 4.0% | ||
| Q2 24 | 18.2% | 0.5% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLGT
暂无分部数据
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
